TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AdAlta Ltd. ( (AU:1AD) ) has provided an update.
AdAlta Ltd. has announced a proposed issue of securities, involving the issuance of 83,333,334 options expiring in 2028 and 13,009,463 fully paid ordinary shares. This strategic move is aimed at raising capital to support the company’s ongoing research and development efforts, potentially enhancing its market position and providing new opportunities for stakeholders.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on the development of innovative therapeutic products. The company is known for its proprietary i-body technology, which is used to develop novel treatments for a range of diseases, with a particular emphasis on fibrotic diseases and cancer.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.84M
Learn more about 1AD stock on TipRanks’ Stock Analysis page.